Overview

Safety/Efficacy of Bromfenac Ophthalmic Solution for Ocular Inflammation and Pain Associated With Cataract Surgery

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate the efficacy and safety of bromfenac ophthalmic solution for treatment of ocular inflammation and pain in subjects who undergo cataract extraction and intraocular lens implantation.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
Anti-Inflammatory Agents, Non-Steroidal
Bromfenac
Ophthalmic Solutions
Pharmaceutical Solutions